ClinicalTrials.gov
public full text
Public Domain
TEsting METformin Against Cognitive Decline in HD
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical and Metabolic Predictors of Cognitive Impairment in Type 1 Diabetes: The Role of Peripheral Neuropathy and Hypoglycaemia Unawareness. Findings From a HAD‐1 Study.#193668
- Evaluating Metformin Efficacy in ALS Using Real-World Data: A Causal Inference Approach#10222
- Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity#172476
- TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID Symptoms#981663
- A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis#405123
Record · ID 221632
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive